1 week Ago By ABMN Staff
Pictet Asset Management Holding SA boosted its holdings in Option Care Health, Inc. ( NASDAQ:OPCH – Free Report ) by 12.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
The firm owned 32,885 shares of the company’s stock after buying an additional 3,738 shares during the period. Pictet Asset Management Holding SA’s holdings in Option Care Health were worth $763,000 as of its most recent SEC filing. Other hedge funds and other institutional investors have also recently bought and sold shares of the company.
Graypoint LLC bought a new position in shares of Option Care Health in the 4th quarter worth $1,161,000. Charles Schwab Investment Management Inc. boosted its holdings in Option Care Health by 6.
2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after buying an additional 147,054 shares during the last quarter.
Global Alpha Capital Management Ltd. grew its position in shares of Option Care Health by 38.1% during the 4th quarter.
Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock worth $1,596,000 after buying an additional 18,992 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in shares of Option Care Health in the 4th quarter valued at about $327,000.
Finally, Barclays PLC raised its position in shares of Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after acquiring an additional 199,454 shares during the period.
98.05% of the stock is owned by institutional investors. Option Care Health Stock Down 2.
0 % NASDAQ:OPCH opened at $32.87 on Tuesday. The stock has a 50-day simple moving average of $33.
00 and a 200 day simple moving average of $28.50. Option Care Health, Inc.
has a 52-week low of $21.39 and a 52-week high of $35.53.
The company has a market cap of $5.40 billion, a PE ratio of 27.62, a PEG ratio of 2.
30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.
77, a quick ratio of 1.32 and a current ratio of 1.73.
Insiders Place Their Bets Analysts Set New Price Targets A number of research analysts recently issued reports on OPCH shares. JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down previously from $31.
00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.
00 in a research note on Monday, January 13th. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.
00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $26.
00 to $35.00 in a research report on Thursday, January 23rd. Finally, Barrington Research lifted their price objective on Option Care Health from $33.
00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock.
According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $33.00. Get Our Latest Stock Analysis on OPCH Option Care Health Company Profile ( Free Report ) Option Care Health, Inc offers home and alternate site infusion services in the United States.
The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. Featured Stories Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter .
.
